NeOnc President Continues Contrarian Buying Amid 31% YTD Decline, Stoking Insider Confidence in a Low‑Priced Stock
Insider buying in NeOnc Technologies shows contrarian confidence amid a 31 % drop; weekly $10k purchases suggest undervaluation but high risk.
- Neonc Technologies Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read

